Halozyme Therapeutics Inc (NASDAQ:HALO)

16.86
Delayed Data
As of Apr 24
 -0.085 / -0.50%
Today’s Change
6.88
Today|||52-Week Range
17.27
+74.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.1B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders31.58%
Other institutional28.92%
Individual stakeholders21.92%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account